Immune-Mediated Therapies for Liver Cancer

被引：23

作者：

Aravalli, Rajagopal N. ^{[1
]}

Steer, Clifford J. ^{[2
]}

机构：

[1] Univ Minnesota, Dept Elect & Comp Engn, 200 Union St SE, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Dept Med & Genet Cell Biol & Dev, 420 Delaware St SE, Minneapolis, MN 55455 USA

来源：

GENES | 2017年 / 8卷 / 02期

关键词：

adaptive immunity; adoptive cell transfer; cancer vaccines; cholangiocarcinoma; hepatocellular carcinoma; immune checkpoint blockade; immunotherapy; innate immunity; tumor immunology; INDUCED KILLER-CELLS; HUMAN CHOLANGIOCARCINOMA CELLS; TUMOR-ASSOCIATED MACROPHAGES; ANTIGEN-PRESENTING CELLS; HEPATOCELLULAR-CARCINOMA; T-CELL; ANTIPLATELET THERAPY; KUPFFER CELLS; ADOPTIVE IMMUNOTHERAPY; RECURRENCE RATES;

D O I：

10.3390/genes8020076

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

In recent years, immunotherapy has gained renewed interest as an alternative therapeutic approach for solid tumors. Its premise is based on harnessing the power of the host immune system to destroy tumor cells. Development of immune-mediated therapies, such as vaccines, adoptive transfer of autologous immune cells, and stimulation of host immunity by targeting tumor-evasive mechanisms have advanced cancer immunotherapy. In addition, studies on innate immunity and mechanisms of immune evasion have enhanced our understanding on the immunology of liver cancer. Preclinical and clinical studies with immune-mediated therapies have shown potential benefits in patients with liver cancer. In this review, we summarize current knowledge and recent developments in tumor immunology by focusing on two main primary liver cancers: hepatocellular carcinoma and cholangiocarcinoma.

引用

页数：20

共 145 条

[61] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma [J].

Lee, Joon Hyeok ;

Lee, Jeong-Hoon ;

Lim, Young-Suk ;

Yeon, Jong Eun ;

Song, Tae-Jin ;

Yu, Su Jong ;

Gwak, Geum-Youn ;

Kim, Kang Mo ;

Kim, Yoon Jun ;

Lee, Jae Won ;

Yoon, Jung-Hwan .

GASTROENTEROLOGY, 2015, 148 (07) :1383-+

[62] Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy [J].

Lee, Ju Yeon ;

Lee, Hyun Tae ;

Shin, Woori ;

Chae, Jongseok ;

Choi, Jaemo ;

Kim, Sung Hyun ;

Lim, Heejin ;

Heo, Tae Won ;

Park, Kyeong Young ;

Ryu, Seong Eon ;

Son, Ji Young ;

Lee, Jee Un ;

Heo, Yong-Seok .

NATURE COMMUNICATIONS, 2016, 7

[63] Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection [J].

Lee, Pei-Chang ;

Yeh, Chiu-Mei ;

Hu, Yu-Wen ;

Chen, Chun-Chia ;

Liu, Chia-Jen ;

Su, Chien-Wei ;

Huo, Teh-Ia ;

Huang, Yi-Hsiang ;

Chao, Yee ;

Chen, Tzeng-Ji ;

Lin, Han-Chieh ;

Wu, Jaw-Ching .

ANNALS OF SURGICAL ONCOLOGY, 2016, 23 :S874-S883

[64] An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells [J].

Lee, Woo-Yong ;

Moriarty, Tara J. ;

Wong, Connie H. Y. ;

Zhou, Hong ;

Strieter, Robert M. ;

van Rooijen, Nico ;

Chaconas, George ;

Kubes, Paul .

NATURE IMMUNOLOGY, 2010, 11 (04) :295-U36

[65] The tumor microenvironment in hepatocellular carcinoma [J].

Leonardi, Giulia Costanza ;

Candido, Saverio ;

Cervello, Melchiorre ;

Nicolosi, Daria ;

Raiti, Fabio ;

Travali, Salvatore ;

Spandidos, Demetrios A. ;

Libra, Massimo .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) :1733-1747

[66] Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients [J].

Li, Fu-Jun ;

Zhang, Ying ;

Jin, Guang-Xin ;

Yao, Lei ;

Wu, De-Quan .

IMMUNOLOGY LETTERS, 2013, 150 (1-2) :116-122

[67] Role of toll-like receptors in changes in gene expression and NF-κB activation in mouse hepatocytes stimulated with lipopolysaccharide [J].

Liu, SB ;

Gallo, DJ ;

Green, AM ;

Williams, DL ;

Gong, XY ;

Shapiro, RA ;

Gambotto, AA ;

Humphris, EL ;

Vodovotz, Y ;

Billiar, TR .

INFECTION AND IMMUNITY, 2002, 70 (07) :3433-3442

[68] Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient [J].

Loeffler, Markus W. ;

Chandran, P. Anoop ;

Laske, Karoline ;

Schroeder, Christopher ;

Bonzheim, Irina ;

Walzer, Mathias ;

Hilke, Franz J. ;

Trautwein, Nico ;

Kowalewski, Daniel J. ;

Schuster, Heiko ;

Guender, Marc ;

Yanez, Viviana A. Carcamo ;

Mohr, Christopher ;

Sturm, Marc ;

Huu-Phuc Nguyen ;

Riess, Olaf ;

Bauer, Peter ;

Nahnsen, Sven ;

Nadalin, Silvio ;

Zieker, Derek ;

Glatzle, Joerg ;

Thiel, Karolin ;

Schneiderhan-Marra, Nicole ;

Clasen, Stephan ;

Boesmueller, Hans ;

Fend, Falko ;

Kohlbacher, Oliver ;

Gouttefangeas, Cecile ;

Stevanovic, Stefan ;

Koenigsrainer, Alfred ;

Rammensee, Hans-Georg .

JOURNAL OF HEPATOLOGY, 2016, 65 (04) :849-855

[69] Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma [J].

Lu, Sheng-Nan ;

Wang, Jing-Houng ;

Liu, Shiann-Long ;

Hung, Chao- Hung ;

Chen, Chien-Hung ;

Tung, Hung-Da ;

Chen, Tsung-Ming ;

Huang, Wu-Shiung ;

Lee, Chuan-Mo ;

Chen, Chia-g Chen ;

Changchien, Chi-Sin .

CANCER, 2006, 107 (09) :2212-2222

[70]

Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11

← 2 3 4 5 6 7 8 9 10 11 →